Description:

RIVANCA contains Rivaroxaban, a direct Factor Xa inhibitor used as an oral anticoagulant to prevent and treat thromboembolic disorders. It offers a convenient, fixed-dose alternative to warfarin, with predictable pharmacokinetics and no need for routine INR monitoring.

Rivaroxaban works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade, thereby reducing the risk of clot formation without the need for a co-factor such as antithrombin III.